PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive Vice President R&D
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2014-03-03$4.70/sh+66,000$310,200→ 66,000 totalExercise: $4.70Exp: 2024-03-03→ Common Stock (66,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.